Who are the key players in North America RSV Diagnostics Market industry?

The key players in the North America RSV Diagnostics Market include Abbott Laboratories, Becton Dickinson & Company, bioMérieux SA, Thermo Fisher Scientific Inc., and F. Hoffmann-La Roche Ltd. These companies are recognized for their innovative RSV diagnostic products, wide distribution networks, and significant ongoing investments in research and development.

What is the North America RSV Diagnostics Market growth?

The North America RSV Diagnostics Market is experiencing robust growth, with a compound annual growth rate (CAGR) of over 9% from 2021 to 2024. Becton Dickinson & Company has seen increased adoption of their rapid antigen tests, driven by rising RSV infection rates and improvements in diagnostic technologies.

Which segment accounted for the largest North America RSV Diagnostics Market share?

The hospitals segment held the largest share of the North America RSV Diagnostics Market. Hospitals rely heavily on advanced diagnostic tests for timely RSV detection, leading to quicker treatment decisions. The need for rapid and accurate diagnostics in critical care settings continues to drive adoption in hospital environments.

What are the factors driving the North America RSV Diagnostics Market?

Recent drivers include a rise in RSV infection rates among infants and the elderly, along with increasing awareness of early diagnosis. For example, Abbott Laboratories has advanced point-of-care RSV tests which boost prompt detection, improving patient outcomes and contributing to overall market expansion.

Which type accounted for the largest North America RSV Diagnostics Market share?

The molecular diagnostics segment accounted for the largest share of the North America RSV Diagnostics Market. Molecular tests are favored due to their high sensitivity and accuracy in detecting RSV, enabling faster diagnosis and appropriate therapeutic interventions, especially during peak RSV seasons.

Home Healthcare

North America RSV Diagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America RSV Diagnostics Market: by Type (Rapid Antigen Detection Tests, Molecular Diagnostics, Immunoassays, Chromatography, Others), Application (Hospitals, Clinics, Laboratories, Home Care, Research Institutes, Others), Distribution Channels (Direct Sales, Distributors, Online, Pharmacies, Retail Stores, Others), Technology (PCR, Immunofluorescence Assay, Enzyme-Linked Immunosorbent Assay, Lateral Flow Immunoassay, Biosensors, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20322

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1020
Regions	United States, Canada, Mexico
Segments	Rapid Antigen Detection Tests, Molecular Diagnostics, Immunoassays, Chromatography, Others, Hospitals, Clinics, Laboratories, Home Care, Research Institutes, Others, Direct Sales, Distributors, Online, Pharmacies, Retail Stores, Others, PCR, Immunofluorescence Assay, Enzyme-Linked Immunosorbent Assay, Lateral Flow Immunoassay, Biosensors, Others, Small, Medium, Large
Players	Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Danaher Corporation, BioMérieux SA, QuidelOrtho Corporation, Hologic, Inc., Siemens Healthineers AG, Luminex Corporation, Meridian Bioscience, Inc., GenMark Diagnostics, Inc., Alere Inc., Sekisui Diagnostics, Cepheid

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1020
Regions	United States, Canada, Mexico
Segments	Rapid Antigen Detection Tests, Molecular Diagnostics, Immunoassays, Chromatography, Others, Hospitals, Clinics, Laboratories, Home Care, Research Institutes, Others, Direct Sales, Distributors, Online, Pharmacies, Retail Stores, Others, PCR, Immunofluorescence Assay, Enzyme-Linked Immunosorbent Assay, Lateral Flow Immunoassay, Biosensors, Others, Small, Medium, Large
Players	Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Danaher Corporation, BioMérieux SA, QuidelOrtho Corporation, Hologic, Inc., Siemens Healthineers AG, Luminex Corporation, Meridian Bioscience, Inc., GenMark Diagnostics, Inc., Alere Inc., Sekisui Diagnostics, Cepheid